Mylab is stoked to announce the approval of Cy-TB, the cutting-edge third-generation test for latent TB infection (LTBI) by Serum Institute of India. This remarkable test represents one of the latest breakthroughs in LTBI diagnosis and presents a novel approach to the TB skin test. Having fast, accurate, and cost-effective molecular diagnostic capabilities, the Cy-TB test marks a significant advancement in the field.
Considering the crucial goal of TB elimination, the testing and treatment of LTBI hold utmost importance. With the advent of Cy-TB, we are now equipped with a powerful tool to further this mission and enhance our efforts to combat TB.